Canada Markets close in 4 hrs 10 mins

NextCure, Inc. (NXTC)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
1.4300-0.0200 (-1.38%)
As of 11:37AM EST. Market open.
Currency in USD

Valuation Measures4

Market Cap (intraday) N/A
Enterprise Value N/A
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)N/A
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA N/A

Trading Information

Stock Price History

Beta (5Y Monthly) 0.17
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 36.6300
52 Week Low 31.4000
50-Day Moving Average 32.4694
200-Day Moving Average 34.0271

Share Statistics

Avg Vol (3 month) 3106.24k
Avg Vol (10 day) 3110.5k
Shares Outstanding 527.63M
Implied Shares Outstanding 6N/A
Float 818.08M
% Held by Insiders 18.77%
% Held by Institutions 158.57%
Shares Short (Oct 13, 2022) 4537.41k
Short Ratio (Oct 13, 2022) 47.88
Short % of Float (Oct 13, 2022) 41.96%
Short % of Shares Outstanding (Oct 13, 2022) 41.94%
Shares Short (prior month Sept 14, 2022) 4607.13k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2021
Most Recent Quarter (mrq)Jun 29, 2022

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-19.33%
Return on Equity (ttm)-31.78%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)-4.08M
EBITDA -66.58M
Net Income Avi to Common (ttm)-73.39M
Diluted EPS (ttm)-1.3290
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)185.49M
Total Cash Per Share (mrq)6.68
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)33.87
Book Value Per Share (mrq)10.65

Cash Flow Statement

Operating Cash Flow (ttm)-56.05M
Levered Free Cash Flow (ttm)-30.49M